| 000 | 01834 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518044337.0 | ||
| 264 | 0 | _c20200310 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1096-8652 | ||
| 024 | 7 |
_a10.1002/ajh.25558 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerry, Chava | |
| 245 | 0 | 0 |
_aCharacteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _c09 2019 |
||
| 300 |
_a992-1001 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnthracyclines _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCentral Nervous System Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aBen Barouch, Sharon | |
| 700 | 1 | _aGoldschmidt, Neta | |
| 700 | 1 | _aSarid, Nadav | |
| 700 | 1 | _aHerishanu, Yair | |
| 700 | 1 | _aShvidel, Lev | |
| 700 | 1 | _aBairey, Osnat | |
| 700 | 1 | _aLavi, Noa | |
| 700 | 1 | _aHorowitz, Netanel | |
| 700 | 1 | _aAvigdor, Avraham | |
| 700 | 1 | _aLebel, Eyal | |
| 700 | 1 | _aSofer, Orit | |
| 700 | 1 | _aRam, Ron | |
| 700 | 1 | _aAvivi, Irit | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 94 _gno. 9 _gp. 992-1001 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.25558 _zAvailable from publisher's website |
| 999 |
_c29810385 _d29810385 |
||